China artificial tears market is estimated to grow considerably at a CAGR of around 5.2% during the forecast period. China has been anticipated to witness considerable growth in the artificial tears market due to a considerable rise in the aging population in the country. According to the State Council of the People’s Republic of China, the country had over 230.8 million people with the age of 60 or more in 2016. It represents 16.7% of the overall population in China. Among these people, nearly 150 million people aged 60 or over, which is 10.8% of the overall population. According to the United Nations (UN), China will take 20 years to double the proportion of the elderly population from 10% to 20% during the period (2017-2037).
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/china-artificial-tears-market
In 2016, China had adopted a 13th 5-year national plan for eye health (2016-2020). Under this plan, the supporting measures are taken at all levels by Health and Family Planning Commissions that are focused on putting significant attention to eye disease treatment and prevention. In addition, it involves promoting eye health awareness and set up a favorable environment for eye care. Around 90% of the counties have medical care institutes of eye health and of which 90% can perform cataract procedure. This plan is focused on appointing new personnel for the treatment of eye diseases. Such government initiatives may lead to encourage healthcare infrastructure for eye treatment, which in turn, is expected to fuel the adoption of artificial tears for the treatment of dry eye diseases.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/china-artificial-tears-market
The companies which are contributing to the growth of China artificial tears market include Carl Zeiss Meditec AG, Allergan PLC, Johnson & Johnson Services, Inc., Nidek Co., Ltd., and Santen Pharmaceutical Co., Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Market Segmentation
China Artificial Tears Market by Type
- Cellulose Derived Tears
- Glycerin Derived Tears
- Oil-Based Emulsion Tears
China Artificial Tears Market by Delivery Method
- Artificial Eye Drops
- Ointments
China Artificial Tears Market by Application
- Dry Eyes Treatment
- Contact Lens Moisture
- Others
Company Profiles
- Allergan PLC
- Bausch & Lomb Inc.
- Carl Zeiss Meditec AG
- Johnson & Johnson Services, Inc.
- Nicox S.A.
- Nidek Co., Ltd.
- OCuSOFT, Inc.
- Santen Pharmaceutical Co., Ltd.
- STAAR Surgical Co.
- Topcon Corp.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
